NCT02506998View on ClinicalTrials.gov

Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Allergic Rhinoconjunctivitis
Interventions
BIOLOGICAL

DLE

Adjuvant treatment

OTHER

Second generation anti histamines + Nasal corticosteroids

Standard treatment

All Listed Sponsors
collaborator

Instituto de Oftalmología Fundación Conde de Valenciana

OTHER

lead

National Polytechnic Institute, Mexico

OTHER

NCT02506998 - Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts | Biotech Hunter | Biotech Hunter